Itoprid Pmcs (Itopride Hydrochloride)

Itopride acts by blocking dopamine D2 receptors in the gut, removing an inhibitory signal on smooth‑muscle contraction, while also inhibiting acetylcholinesterase. The resulting increase in acetylcholine stimulates cholinergic pathways, promoting coordinated peristalsis and faster gastric emptying.

The prescribed dose of Itoprid Pmcs is determined by the treating physician based on the patient’s clinical condition, age, renal and hepatic function, and response to therapy. Dosage instructions should always follow the prescriber’s recommendation.

Safety data for itopride during pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Compared with other prokinetics such as metoclopramide or domperidone, itopride has a dual mechanism—dopamine antagonism plus acetylcholinesterase inhibition—which may offer a broader enhancement of gut motility while having a lower risk of extrapyramidal side effects. Clinical choice depends on patient profile and physician judgment.

Itoprid Pmcs should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing in humid or excessively hot environments.

Itoprid Pmcs is taken orally, usually with or without food, as directed by the prescribing clinician. The tablet (or other oral form) should be swallowed whole with water and not crushed or chewed unless specifically instructed.

Serious adverse events, although rare, can include severe allergic reactions such as anaphylaxis, cardiac arrhythmias, significant liver enzyme elevations, neutropenia, and pancreatitis. Patients should seek immediate medical attention if they experience symptoms like rash, difficulty breathing, chest pain, jaundice or unexplained fever.

Itoprid Pmcs is contraindicated in individuals with known hypersensitivity to itopride or any of the product’s excipients. Caution is advised for patients with severe renal or hepatic impairment, those taking other dopamine antagonists, and patients with a history of cardiac arrhythmias until evaluated by a physician.